Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Oncology Regulatory Science

Amy Abernethy

艾米·阿伯内西

MD, PhD

🏢Verily Life Sciences / formerly FDA(Verily生命科学公司/前美国FDA)🌐USA

Chief Medical Officer (former FDA Principal Deputy Commissioner)首席医疗官(前FDA首席副局长)

55
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Amy Abernethy is a leading voice in real-world evidence and digital health regulation for oncology. As FDA Principal Deputy Commissioner, she drove modernization of clinical trial infrastructure and real-world data policies. Her research spans symptom science, outcomes, and data-driven oncology care.

Share:

🧪Research Fields 研究领域

Real-World Evidence真实世界证据
Digital Health数字健康
Oncology Data Science肿瘤数据科学
FDA Regulatory PolicyFDA监管政策

🎓Key Contributions 主要贡献

Real-World Evidence in Oncology Regulation

Developed frameworks for using real-world data and evidence in FDA drug approvals, particularly for oncology, accelerating access to effective treatments.

Digital Health and Clinical Trials

Pioneered integration of digital health tools and decentralized trial designs in oncology, broadening patient access and improving data quality.

Oncology Symptom Science

Built research programs at Duke and Flatiron Health linking patient-reported outcomes to regulatory endpoints, influencing how FDA evaluates cancer drug benefits.

Representative Works 代表性著作

[1]

The Promise of Digital Health: Then, Now, and the Future

NAM Perspectives (2022)

Articulated the regulatory and clinical potential of digital technologies in transforming healthcare and clinical research.

[2]

Pragmatic Approaches to Expand Clinical Trial Eligibility: Moving Beyond Limitations

American Society of Clinical Oncology Educational Book (2017)

Influenced broader and more inclusive oncology trial enrollment criteria.

[3]

Electronic Patient-Reported Outcomes Support Clinical Practice and Effective Symptom Management

Journal of Oncology Practice (2010)

Demonstrated the value of ePRO tools in oncology care delivery and outcomes research.

🏆Awards & Recognition 奖项与荣誉

🏆Flatiron Health Oncology Leadership Award
🏆ASCO Health Information Technology Award
🏆FDA Commissioner's Special Citation for COVID-19 Response

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 艾米·阿伯内西 的研究动态

Follow Amy Abernethy's research updates

留下邮箱,当我们发布与 Amy Abernethy(Verily Life Sciences / formerly FDA)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment